Pancreatic Cancer Treatment Market By Treatment Type (Surgery {Whipple Procedure, Distal Pancreatectomy, Total Pancreatectomy}, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy, Palliative Care, Others), By Drug Type (Approved Drugs {Gemcitabine, Nab-Paclitaxel, Erlotinib, Liposomal Irinotecan}, Pipeline Drugs {Oncolytic Viruses, Epigenetic Modulators}), By Cancer Type (Exocrine Pancreatic Cancer, Pancreatic Neuroendocrine Tumors, Others), By Route of Administration (Oral, Injectable {Intravenous, Intraperitoneal}), and By End-User (Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Dec 2024 | Report ID: MI1582 | 210 Pages


Report Coverage:

By Treatment Type

  • Surgery
    • Whipple Procedure
    • Distal Pancreatectomy
    • Total Pancreatectomy   
  • Radiation Therapy
  • Chemotherapy
  • Targeted Therapy
  •  Immunotherapy
  • Palliative Care
  •  Others

By Drug Type

Approved Drugs

  • Gemcitabine
  • Nab-Paclitaxel
  • Erlotinib
  • Liposomal Irinotecan
  • Pipeline Drugs
    • Oncolytic Viruses
    • Epigenetic Modulators

By Cancer Type

  • Exocrine Pancreatic Cancer
  • Pancreatic Neuroendocrine Tumors
  • Others

By Route of Administration

  • Oral
  • Injectable
    • Intravenous
    • Intraperitoneal

By End-User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Cancer Research Institutes
  • Others

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

List of Companies:

  • Celgene Corporation
  • Eli Lilly and Co.
  • Amgen Inc.
  • Merck & Co.
  • Genentech
  • Novartis International AG
  • AbbVie Inc.
  • Bayer AG
  • Sanofi
  • Ipsen Pharma
  • Bristol-Myers Squibb
  • OncoOne
  • Exelixis, Inc.
  • Karyopharm Therapeutics
  • Clovis Oncology

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.